Macrophage infiltration and low‐grade inflammation in abdominal obesity may lead to dyslipidemia, lipoprotein peroxidation, and liver steatosis, and these factors promote the development of atherosclerosis and induce CD36 in the vascular wall. The gene discussed is CD36; the disease is metabolic syndrome.